A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection
Korean Journal of Ophthalmology
;
: 57-59, 2011.
Artigo
em Inglês
| WPRIM
| ID: wpr-121935
ABSTRACT
We report the first case of ocular benign lymphoid hyperplasia (BLH) treated with subconjunctival injection of bevacizumab (Avastin). A 27-year-old man presented to our clinic with conjunctival masses and limbal neovascularization. An incisional biopsy yielded the diagnosis of BLH. The patient was subsequently given a subconjunctival injection of bevacizumab (1.25 mg / 0.1 mL). The patient did not experience recurrence or malignant metaplasia during the one-year follow-up period. In patients with conjunctival BLH, subconjunctival injection of bevacizumab can be a useful treatment option in patients unable to undergo a surgical procedure due to limbal neovascularization.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Limbo da Córnea
/
Túnica Conjuntiva
/
Doenças da Túnica Conjuntiva
/
Inibidores da Angiogênese
/
Injeções Intraoculares
/
Hiperplasia
/
Tecido Linfoide
/
Anticorpos Monoclonais
/
Neovascularização Patológica
Limite:
Adulto
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Korean Journal of Ophthalmology
Ano de publicação:
2011
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS